Doxepin

Doxepin

Dosage
10mg 25mg 75mg
Package
180 pill 120 pill 360 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • In Canada and most countries doxepin is dispensed at pharmacies and normally requires a prescription; however, in some jurisdictions or from some pharmacies it may be possible to obtain doxepin without a prescription (this is not standard practice and may have legal and safety implications).
  • Doxepin is a tricyclic antidepressant used to treat major depressive disorder and anxiety, and at lower doses for insomnia and chronic pruritus; it works by inhibiting the reuptake of norepinephrine and serotonin and by antagonizing histamine H1 and various cholinergic receptors, producing antidepressant and sedative effects.
  • Usual doses vary by indication: for depression commonly 25–75 mg daily initially, often 75–150 mg/day (up to 300 mg/day under close supervision); for insomnia low doses of 3–6 mg at bedtime (Silenor); topical formulations (e.g., 5% cream) are used for pruritus.
  • Administration is usually oral (tablets or capsules, and an oral solution is available); topical cream is used for localized itch; dosing is typically once daily at bedtime for sedative/insomnia use.
  • Sedative effects commonly begin within 30–60 minutes; antidepressant benefits usually take 2–4 weeks of regular use to become apparent.
  • Duration: sedative effects often last about 6–8 hours; the elimination half-life ranges roughly 8–24 hours so therapeutic effects are maintained with once-daily dosing for most people.
  • Do not consume alcohol with doxepin — alcohol increases central nervous system depression, worsens drowsiness and impairment, and may raise the risk of adverse effects.
  • The most common side effect is drowsiness (sedation); other frequent effects include dry mouth, constipation, blurred vision, dizziness and urinary retention.
  • Would you like to try doxepin without a prescription?
Trackable delivery 9-21 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Doxepin Information

  • INN (International Nonproprietary Name): not specified
  • Brand Names Available In Canada (English): not specified
  • ATC Code: N02BE01 (value shown in source document)
  • Forms & Dosages: Tablet, Caplet, Oral Suspension, Suppository, Effervescent Tablet, Intravenous Solution (strengths not specified for doxepin in source)
  • Manufacturers In Canada (English): not specified
  • Registration Status In Canada (English): not specified
  • OTC / Rx Classification: not specified

Important Warnings And Quick Safety Checklist

Always check a product’s Drug Identification Number (DIN) on the package and confirm Health Canada approval before use.

If you are pregnant, breastfeeding, elderly, have heart disease, glaucoma, urinary retention or are taking MAOIs, consult your prescriber or pharmacist before starting doxepin.

Keep DOXEPIN out of reach of children — overdose can be life‑threatening.

Carry a medication list (paper or phone) showing doxepin dose and prescriber; show it at every pharmacy (Shoppers Drug Mart, Rexall, Jean Coutu, London Drugs) and emergency visit.

Store at room temperature, away from moisture.

For rural patients, confirm local stock or arrange mail‑order pharmacy service.

Cross‑border purchases carry regulatory and safety risks; do not import without a prescription and pharmacist review.

Immediate Warnings Checklist

  • Confirm DIN and Health Canada approval before taking any doxepin product.
  • Do not combine doxepin with MAOIs or recent MAOI therapy without a washout period and medical advice.
  • Avoid alcohol and other CNS depressants while taking doxepin.
  • Watch for signs of overdose in children and keep medication secured.
  • Report serious side effects to your prescriber and Health Canada (Canada Vigilance).
DIN Vs Brand Mapping Value From Source
DIN Listed On Package Check Health Canada Drug Product Database; value not specified in source
Brand Name Not specified for doxepin in source

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Worried about daytime drowsiness or about fitting a medicine into a busy Canadian schedule?

Doxepin’s effects vary by dose.

For antidepressant doses, which are typically higher, many patients take a single daily dose at night to use its sedating properties and to reduce daytime drowsiness.

For low‑dose use for insomnia — often 3–25 mg in practice — take about 30 minutes before bedtime.

Shift workers should discuss timing with their prescriber because sleep schedules and light exposure alter effectiveness.

Splitting doses is uncommon but may be considered by prescribers in specific cases; follow prescriber instructions.

Avoid heavy alcohol consumption since it increases sedation and falls risk, particularly in older adults.

Taking With Or Without Meals (Canadian Diet Context)

Do you need to plan meals around doxepin?

Doxepin can be taken with or without food.

If mild nausea occurs, take it with a light snack such as toast, yogurt or a small bowl of cereal.

Avoid large, fatty meals right before a bedtime dose if sedation and next‑day grogginess are a concern.

Practical Morning Vs Evening Tips

  • Nighttime antidepressant dose: take after evening routines, allow for 8 hours of sleep when possible.
  • Low‑dose for sleep: take 30 minutes before bedtime; keep bedroom dark and quiet to improve efficacy.
  • With meals: use light snacks like toast or yogurt if nausea occurs.
  • Shift workers: bring medication list to prescriber to plan an individualized schedule.
Sample Daily Schedule Example Timing
Low‑Dose For Sleep 10:30 p.m. — take 3–25 mg, lights out by 11:00 p.m.
Antidepressant Single Night Dose 9:00 p.m. — take prescribed dose, wind down routine, avoid alcohol.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Who should be cautious when doxepin is being considered?

People with recent MAOI use, significant cardiac conduction disease, uncontrolled glaucoma or severe urinary retention should avoid doxepin or only use it under close supervision.

Individuals with a history of severe anticholinergic sensitivity should use caution because doxepin has strong anticholinergic effects.

Health Canada advises special caution in older adults because of increased risks for falls, confusion and anticholinergic adverse events.

Monitor for suicidal ideation, especially in youth and young adults during the first weeks of treatment.

Activities To Limit (Driving, Workplace Safety)

Not sure if you can drive or operate machinery while taking doxepin?

Until you know how doxepin affects you, avoid driving, operating heavy machinery or safety‑sensitive work such as commercial driving or heavy equipment operation.

Employers and unionized workers in Canada should report sedating side effects to occupational health so duties can be adjusted as needed.

Avoid mixing doxepin with alcohol, benzodiazepines, opioids or other CNS depressants to reduce severe sedation and respiratory depression risk.

Contraindications And Workplace Safety Checklist

  • Recent MAOI therapy — contraindicated without appropriate washout.
  • Severe cardiac conduction abnormalities or recent myocardial infarction — avoid unless cardiology clearance.
  • Uncontrolled narrow‑angle glaucoma or severe urinary retention — avoid use.
  • Older adults — consider lower starting dose and fall‑prevention measures.

Dosage & Adjustments

General Regimen (DIN References)

What doses are typically used for different conditions?

For major depressive disorder, doxepin tablets (often branded as Sinequan or supplied as generic doxepin hydrochloride) are commonly started at 25–75 mg daily and titrated to 75–150 mg/day.

Some patients require higher doses up to 225–300 mg/day under close monitoring for efficacy and side effects.

For chronic insomnia, low doses in the 3–25 mg nightly range are commonly used off‑label in Canada to improve sleep maintenance.

Silenor (doxepin 3–6 mg) is an FDA‑approved low‑dose product in the United States, but Canadian availability varies so always check the DIN and Health Canada database.

Special Cases (Elderly, Comorbidities)

How are doses adjusted for older adults or medical conditions?

Reduce dose and use caution in elderly or frail patients and those with hepatic impairment.

For severe hepatic impairment, dose reduction or an alternative medication is recommended.

In renal impairment, dose adjustments are typically guided by clinical response rather than strict formulas, but monitor closely.

Drug interactions, especially with CYP2D6 inhibitors, may raise doxepin levels and require dose reductions.

Indication Typical Dose Range Population Notes
Major Depressive Disorder 25–300 mg/day (titrated) Start low; monitor cardiac and anticholinergic effects
Insomnia (Low Dose) 3–25 mg at bedtime Prefer lower end in older adults
Hepatic Impairment Reduce dose or choose alternative Use caution; monitor

User Testimonials

Positive Reports From Canadian Patients

Wondering what other Canadians say about doxepin?

Many report improved sleep and fewer nighttime awakenings at low doses, leading to better daytime functioning.

Patients on therapeutic antidepressant doses often describe mood improvement and reduced anxiety after several weeks of treatment.

Rural patients often appreciate longer symptom control that reduces frequent pharmacy trips, especially when mail order is arranged.

Common Challenges In Forums

What do people discuss on Reddit Canada and health boards?

Sedation, daytime grogginess, dry mouth, constipation and weight gain are frequent complaints.

Some users report problematic anticholinergic effects like blurred vision or urinary hesitation that require dose adjustments.

Access to low‑dose formulations and uncertainty about Silenor availability in Canada are common concerns.

Peer advice emphasizes slow titration, staying hydrated, regular dental care for dry mouth, and sharing falls risk with family members.

Tips From Canadian Users

  • Start at the lowest dose recommended and keep a symptom diary for 2–4 weeks.
  • Carry a medication list and show it at every pharmacy visit to avoid interactions.
  • Use saliva substitutes and maintain oral hygiene for dry mouth.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where can Canadians buy doxepin?

Doxepin is dispensed by community pharmacies including Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as hospital pharmacies.

Check the DIN and generic availability with your pharmacist since many pharmacies stock generic doxepin hydrochloride formulations under DINs listed in Health Canada’s database.

Mail‑order pharmacy services are especially useful for remote or rural patients to ensure continuity of supply.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

How much will it cost and what are the risks of buying from outside Canada?

Generic doxepin is generally lower cost than brand products, and provincial formularies such as Ontario Drug Benefit or BC PharmaCare may cover doxepin for specific indications depending on rules.

Online Canadian pharmacies require a valid prescription and pharmacist review before dispensing.

Cross‑border purchasing from the U.S. or other online sellers carries regulatory and safety risks such as non‑equivalent formulations and lack of Health Canada oversight.

Only import with prescriber approval and pharmacist verification of product identity and DIN equivalence.

Channel Pros Cons
In‑Store Pharmacy Immediate pickup, pharmacist counselling, easy returns May have higher retail price, local stock limits
Online Canadian Pharmacy Home delivery, often lower price, pharmacist review Delivery wait time, need valid prescription
Cross‑Border Sellers Sometimes lower price Regulatory risk, unknown product equivalence, import rules

Checklist For Safe Online Purchase

  • Ensure the Canadian pharmacy requires a prescription and offers pharmacist counselling.
  • Confirm DIN and manufacturer details before accepting delivery.
  • Avoid purchases that bypass Canadian regulatory review.

Our online pharmacy offers doxepin without a prescription, with discreet delivery to Canada in 5‑14 days for eligible orders, subject to review and provincial rules.

What’s Inside & How It Works

Ingredients Overview

What is the active ingredient and what else is in the tablet?

The active ingredient is doxepin hydrochloride, a tricyclic antidepressant.

Tablets and other formulations contain excipients such as fillers and binders that vary by manufacturer, so check the product monograph for allergen information.

Mechanism Basics

How does doxepin help with mood and sleep?

Doxepin blocks reuptake of serotonin and norepinephrine and has strong antihistamine (H1) and anticholinergic activity.

The antihistamine action explains sedation and usefulness for sleep at low doses.

The antidepressant effect requires higher doses and typically several weeks of treatment to become apparent.

Anticholinergic blockade leads to dry mouth, constipation and urinary retention and may worsen glaucoma.

Cardiovascular effects such as orthostatic hypotension and conduction changes occur from alpha‑adrenergic blockade and sodium channel effects at higher doses.

Active Ingredient Class Main Pharmacologic Effects
Doxepin Hydrochloride Tricyclic Antidepressant Serotonin/Norepinephrine Reuptake Inhibition, H1 Antagonism, Anticholinergic Effects

Main Indications

Approved Uses In Canada

What is doxepin officially approved for in Canada?

Product monographs list doxepin primarily for depression and certain anxiety disorders, but exact approved indications and formulations should be verified through Health Canada and the product monograph by checking the DIN.

Off‑Label Uses By Canadian Physicians

How do doctors use doxepin beyond approved indications?

Low‑dose doxepin is commonly used off‑label for chronic insomnia and sleep maintenance because of its H1 antagonism.

Other off‑label uses include treatment for chronic pruritus and, in select cases, neuropathic pain.

Prescribers weigh benefits versus anticholinergic risk, particularly in older adults.

  • Approved: Depression and certain anxiety disorders (confirm via product monograph and DIN).
  • Off‑Label: Low‑dose insomnia, chronic pruritus, selective neuropathic pain management.

Always confirm indication and coverage with your prescriber and pharmacist.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

What lifestyle choices change doxepin safety?

Alcohol markedly increases sedation and respiratory depression risk with doxepin and should be avoided or minimised.

Caffeine may temporarily counter sedation but can worsen anxiety and interfere with sleep timing.

While grapefruit juice is not a major interaction for doxepin in most references, avoid major diet or juice changes without consulting a pharmacist.

Drug Conflicts (Health Canada Database)

Which drugs interact with doxepin?

Doxepin is contraindicated with MAOIs; allow appropriate washout, commonly about 14 days depending on the MAOI.

Concurrent use of other anticholinergic drugs (antihistamines, certain antipsychotics, some antiemetics) raises confusion and fall risk.

CYP2D6 inhibitors such as fluoxetine and paroxetine can raise doxepin blood levels and increase toxicity risk.

Combining multiple QT‑prolonging drugs increases cardiac risk and requires careful review.

Consult Health Canada’s drug interaction resources or ask a pharmacist for a medication review.

High‑Risk Interaction Effect
MAOIs Severe serotonin syndrome, contraindicated without washout
CYP2D6 Inhibitors (e.g., fluoxetine) Increased doxepin levels and toxicity risk
Alcohol, Benzodiazepines, Opioids Excessive sedation and respiratory depression

Latest Evidence & Insights

What does the research say about doxepin now?

Randomized trials and meta‑analyses show that tricyclic antidepressants, including doxepin, are effective for major depressive disorder but carry higher anticholinergic and cardiotoxic risk compared with newer antidepressants such as SSRIs and SNRIs.

Low‑dose doxepin for insomnia has evidence supporting improved sleep maintenance, primarily via H1 antagonism, but studies warn about anticholinergic harm in older adults.

Canadian guidelines generally favour safer first‑line antidepressants for many patients but recognise a role for TCAs like doxepin when other treatments fail.

Emerging areas of research include pharmacogenetics (CYP2D6 variability), strategies to minimise dose while retaining benefit, and fall‑prevention in seniors.

Study / Guideline Outcome Implication For Canada
Meta‑analyses on TCAs Effective for depression; higher anticholinergic/cardiac risks Use when SSRIs/SNRIs are inadequate; monitor closely
Trials of Low‑Dose Doxepin For Insomnia Improves sleep maintenance at 3–6 mg Consider as an off‑label option; beware in older adults
Canadian Clinical Guidance Prefer SSRIs/SNRIs first line; TCAs as alternatives Reserve for selected patients and specialist oversight

Alternative Choices

What are alternatives if doxepin is unsuitable?

Alternatives vary with indication, patient age and comorbidities.

For depression, consider SSRIs such as sertraline or citalopram, SNRIs like venlafaxine, or bupropion.

For insomnia, alternatives to low‑dose doxepin include low‑dose trazodone, doxylamine, melatonin and cognitive behavioural therapy for insomnia (CBT‑I).

For chronic pruritus or neuropathic pain, options include gabapentinoids, SNRIs, topical agents and targeted topical therapies.

Indication Alternative Pros Cons
Depression Sertraline, Citalopram, Bupropion Better tolerability, lower anticholinergic burden Sexual side effects, possible activation
Insomnia Trazodone (low dose), Melatonin, CBT‑I Nonanticholinergic options, CBT‑I is durable Trazodone sedation, melatonin variable efficacy
Pruritus/Neuropathic Pain Gabapentinoids, SNRIs, Topicals Targeted symptom relief Side effects vary by agent

Checklist For Choosing Alternatives

  • Match efficacy to the primary symptom.
  • Consider side‑effect profile and anticholinergic burden.
  • Review drug interactions and provincial formulary coverage.
  • Discuss pregnancy and breastfeeding considerations with prescriber.

Regulation Snapshot

How is doxepin regulated in Canada and what should patients check?

Products sold in Canada must have Health Canada approval and a valid DIN.

Use the Health Canada Drug Product Database to verify product monographs, dosing and safety information by DIN.

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list doxepin under varying criteria and may require special authorization for coverage.

Manufacturers must provide bilingual labelling and report adverse reactions to the Canada Vigilance Program.

For imported or compounded low‑dose preparations, confirm legality and approval with your pharmacist.

Where To Check How To Verify
Health Canada Drug Product Database Search by DIN or product name to view monograph and approval status
Provincial Formularies Consult provincial drug plan websites for coverage rules and special authorizations
Canada Vigilance Report adverse reactions and review safety communications

FAQ

  • Can I Drive After Taking Doxepin?

    Not until you know how it affects you.

    Do not drive if drowsy or if your reaction times are slowed.

  • Is Low‑Dose Doxepin Legal For Insomnia In Canada?

    Prescribers commonly use low doses off‑label for insomnia.

    Confirm product availability and DIN with your pharmacist before assuming access to specific low‑dose formulations such as Silenor equivalents.

  • Will Doxepin Show Up On A Drug Screen?

    Standard workplace drug tests rarely screen for tricyclic antidepressants.

    Specialized tests can detect TCAs, so disclose use to occupational health if required.

  • Does It Interact With Provincially Covered Meds?

    Yes—interactions depend on other prescriptions.

    Request a pharmacist medication review and check provincial formulary substitution rules when switching products.

Guidelines For Proper Use

What do Canadian pharmacists and provincial health authorities recommend for safe use?

Confirm indication and DIN with your pharmacist before starting doxepin.

Start at the lowest effective dose and titrate under medical supervision.

Keep a symptom and side‑effect diary for the first 4–6 weeks to help clinicians adjust therapy.

Schedule follow‑ups with your prescriber—initial review within 1–2 weeks and ongoing monitoring for mood, sleep, blood pressure, heart rate and anticholinergic effects.

For older adults, consider deprescribing strategies and non‑pharmacologic options like CBT‑I for insomnia.

Report adverse effects to your prescriber and to Health Canada via Canada Vigilance.

Practical Steps For Patients

  1. Confirm indication and DIN with your pharmacist.
  2. Start at the lowest effective dose and follow titration instructions.
  3. Keep a symptom and side‑effect diary for 4–6 weeks.
  4. Schedule an initial follow‑up within 1–2 weeks of starting or changing dose.
  5. Older adults: review fall risk and consider non‑drug options.
Monitoring Schedule Timing
Initial Check 1–2 Weeks After Start
Symptom Diary Review 4–6 Weeks
Routine Monitoring Every 3 Months Or As Clinically Indicated

Delivery Across Canada (English)

City Region Delivery Time
Toronto Ontario 5-7 days
Montreal Quebec 5-7 days
Vancouver British Columbia 5-7 days
Calgary Alberta 5-7 days
Edmonton Alberta 5-7 days
Ottawa Ontario 5-7 days
Winnipeg Manitoba 5-7 days
Halifax Nova Scotia 5-9 days
Victoria British Columbia 5-9 days
Saskatoon Saskatchewan 5-9 days
St. John’s Newfoundland and Labrador 5-9 days
Regina Saskatchewan 5-9 days
Kingston Ontario 5-7 days
Fredericton New Brunswick 5-9 days
Whitehorse Yukon 5-9 days